News & Events

2026 Virtual Annual Summit for the CAP-IT Program
The upcoming NCI CAP-IT Summit is set to convene a diverse mix of participants, including senior leaders, experts, and emerging talents such as junior investigators and trainees, all dedicated to the fields of cancer prevention and interception.
Immune features of precancer progression: Insights from the HTAN Precancer Atlas
Please join us for a discussion on Immune features of precancer progression: Insights from the HTAN Precancer Atlas DCP Immunology Interest Group Seminar with Shelley Hwang, MD, MPH
DCP Updates: NCAB Meeting, Latest News Articles, and More
Latest News; Upcoming Events

Latest News Releases

Meet the 2026 Cohort of the Early Career Scientists
- Friday, January 23, 2026
The National Cancer Institute (NCI) Division of Cancer Prevention (DCP) is pleased to announce the 2026 cohort of the DCP Early Career Scientists who are advancing cancer research in the areas of prevention, detection, and…
Environmental Exposure–Related Risk in Skin Cancer Webinar
- Thursday, January 22, 2026
Complex environmental exposures—including chemical agents (e.g., air pollution, pesticides), radiation (e.g., ultraviolet light, radon), and lifestyle factors (e.g., diet, tobacco use, alcohol consumption)—can induce DNA damage, and increase cancer risk.
Predicting and Mitigating Nausea and Vomiting
- Friday, September 12, 2025
Webinar on predicting and mitigating nausea and vomiting. Dr. Jim and Dr. Wesmiller will discuss ongoing research and strategies for studying and mitigating cancer-treatment induced nausea and vomiting.
Precision Cancer Immunotherapy for Pancreatic Cancer
- Wednesday, September 10, 2025
Vinod Balachandran is a surgeon-scientist and the Founding Director of The Olayan Center for Cancer Vaccines at Memorial Sloan Kettering, an academic biohub dedicated to advancing next-generation precision cancer vaccines.
State of the Science for Cancer Treatment-related Cardiotoxicities
- Wednesday, July 30, 2025
Dr. Ruddy and Dr. Herrmann will discuss the state of the science in cardio-oncology, management of cardiotoxicities, and exciting new tools and directions for cardio-oncology research.